Human leukocyte antigen class II allele association to disease progression in Iranian patients with chronic lymphocytic leukemia
Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Fazel Shokri(Academic Center for Education, Culture and Research), Mahmood Jeddi‐Tehrani(Academic Center for Education, Culture and Research), Seyed Mohsen Razavi(Firoozgar General Hospital), Hodjatallah Rabbani(Biotechnology Research Center), Ramazan Ali Sharifian(University of Tehran), Ali Akbar Amirzargar(Tehran University of Medical Sciences)
Cited by 14
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202
CDK1 in Breast Cancer: Implications for Theranostic Potential
|Anti-Cancer Agents in Medicinal Chemistry|2020|169
Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer
|Journal of Cellular Physiology|2017|150